INFRARED REFERENCE SPECTRA

The infrared reference spectra presented here were obtained by the use of Fourier-trans-
form infrared spectrophotometers under the conditions specified in the individual mono-
graphs. The horizontal axis indicates the wave numbers (cm－1) and the vertical axis indicates
the transmittance (z). A spectrum of polystyrene obtained in the same manner is also
presented for reference.

Polystyrene
JP XVIII Infrared Reference Spectra 2179

Acebutolol Hydrochloride

Acemetacin

Acetaminophen

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2180 Infrared Reference Spectra JP XVIII

Acetohexamide

Acetylcholine Chloride for Injection

Acetylcysteine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2181

Aciclovir

Aclarubicin Hydrochloride

Acrinol Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2182 Infrared Reference Spectra JP XVIII

Adrenaline

Afloqualone

Alacepril

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2183

L-Alanine

Aldioxa

Alendronate Sodium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2184 Infrared Reference Spectra JP XVIII

Allopurinol

Alminoprofen

Alprenolol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2185

Alprostadil

Amantadine Hydrochloride

Ambenonium Chloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2186 Infrared Reference Spectra JP XVIII

Amidotrizoic Acid

Amikacin Sulfate

Amiodarone Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2187

Amlexanox

Amlodipine Besilate

Amosulalol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2188 Infrared Reference Spectra JP XVIII

Amoxapine

Amoxicillin Hydrate

Anhydrous Ampicillin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2189

Ampicillin Hydrate

Ampicillin Sodium

Ampiroxicam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2190 Infrared Reference Spectra JP XVIII

Amyl Nitrite

Aprindine Hydrochloride

Argatroban Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2191

L-Arginine

L-Arginine Hydrochloride

Arotinolol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2192 Infrared Reference Spectra JP XVIII

L-Aspartic Acid

Aspoxicillin Hydrate

Atenolol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2193

Atorvastatin Calcium Hydrate

Auranofin

Azelastine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2194 Infrared Reference Spectra JP XVIII

Azelnidipine

Azithromycin Hydrate

Azosemide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2195

Bacampicillin Hydrochloride

Beclometasone Dipropionate

Benidipine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2196 Infrared Reference Spectra JP XVIII

Benserazide Hydrochloride

Benzbromarone

Benzyl Alcohol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2197

Benzylpenicillin Benzathine Hydrate

Benzylpenicillin Potassium

Bepotastine Besilate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2198 Infrared Reference Spectra JP XVIII

Beraprost Sodium

Berberine Chloride Hydrate

Berberine Tannate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2199

Betahistine Mesilate

Betamethasone

Betamethasone Dipropionate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2200 Infrared Reference Spectra JP XVIII

Betamethasone Sodium Phosphate

Betamethasone Valerate

Betamipron

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2201

Betaxolol Hydrochloride

Bethanechol Chloride

Bezafibrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2202 Infrared Reference Spectra JP XVIII

Bicalutamide

Bifonazole

Biotin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2203

Biperiden Hydrochloride

Bisacodyl

Bisoprolol Fumarate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2204 Infrared Reference Spectra JP XVIII

Bleomycin Hydrochloride

Bleomycin Sulfate

Bromazepam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2205

Bromfenac Sodium Hydrate

Bromhexine Hydrochloride

Bromocriptine Mesilate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2206 Infrared Reference Spectra JP XVIII

Brotizolam

Bucillamine

Bucumolol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2207

Bufetolol Hydrochloride

Buformin Hydrochloride

Bumetanide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2208 Infrared Reference Spectra JP XVIII

Bunazosin Hydrochloride

Bupivacaine Hydrochloride Hydrate

Bupranolol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2209

Buprenorphine Hydrochloride

Busulfan

Butenafine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2210 Infrared Reference Spectra JP XVIII

Butyl Parahydroxybenzoate

Cabergoline

Cadralazine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2211

Calcium Folinate Hydrate

Calcium Levofolinate Hydrate

Calcium Pantothenate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2212 Infrared Reference Spectra JP XVIII

Calcium Paraaminosalicylate Hydrate

Calcium Polystyrene Sulfonate

Calcium Sodium Edetate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2213

Candesartan Cilexetil

Captopril

Carbazochrome Sodium Sulfonate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2214 Infrared Reference Spectra JP XVIII

Carbidopa Hydrate

L-Carbocisteine

Carboplatin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2215

Carmellose

Carmofur

Carteolol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2216 Infrared Reference Spectra JP XVIII

Carumonam Sodium

Carvedilol

Cefaclor

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2217

Cefadroxil

Cefalexin

Cefalotin Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2218 Infrared Reference Spectra JP XVIII

Cefatrizine Propylene Glycolate

Cefazolin Sodium

Cefazolin Sodium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2219

Cefixime Hydrate

Cefmenoxime Hydrochloride

Cefmetazole Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2220 Infrared Reference Spectra JP XVIII

Cefminox Sodium Hydrate

Cefodizime Sodium

Cefotaxime Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2221

Cefotetan

Cefotiam Hydrochloride

Cefpodoxime Proxetil

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2222 Infrared Reference Spectra JP XVIII

Cefroxadine Hydrate

Cefsulodin Sodium

Ceftazidime Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2223

Cefteram Pivoxil

Ceftibuten Hydrate

Ceftizoxime Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2224 Infrared Reference Spectra JP XVIII

Cefuroxime Axetil

Celecoxib

Cellacefate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2225

Cetirizine Hydrochloride

Cetotiamine Hydrochloride Hydrate

Cetraxate Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2226 Infrared Reference Spectra JP XVIII

Chenodeoxycholic Acid

Chloramphenicol

Chloramphenicol Sodium Succinate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2227

Chlordiazepoxide

Chlormadinone Acetate

Chlorphenesin Carbamate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2228 Infrared Reference Spectra JP XVIII

Chlorpheniramine Maleate

d-Chlorpheniramine Maleate

Chlorpropamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2229

Cholecalciferol

Cibenzoline Succinate

Ciclacillin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2230 Infrared Reference Spectra JP XVIII

Ciclosporin

Cilastatin Sodium

Cilazapril Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2231

Cilnidipine

Cilostazol

Cimetidine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2232 Infrared Reference Spectra JP XVIII

Cinoxacin

Ciprofloxacin

Ciprofloxacin Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2233

Cisplatin

Citicoline

Anhydrous Citric Acid

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2234 Infrared Reference Spectra JP XVIII

Citric Acid Hydrate

Clebopride Malate

Clindamycin Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2235

Clindamycin Phosphate

Clinofibrate

Clobetasol Propionate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2236 Infrared Reference Spectra JP XVIII

Clocapramine Hydrochloride Hydrate

Clofedanol Hydrochloride

Clofibrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2237

Clonazepam

Clonidine Hydrochloride

Cloperastine Fendizoate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2238 Infrared Reference Spectra JP XVIII

Cloperastine Hydrochloride

Clopidogrel Sulfate

Clorazepate Dipotassium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2239

Clotrimazole

Cloxacillin Sodium Hydrate

Cocaine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2240 Infrared Reference Spectra JP XVIII

Codeine Phosphate Hydrate

Colchicine

Colestimide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2241

Colistin Sodium Methanesulfonate

Copovidone

Cortisone Acetate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2242 Infrared Reference Spectra JP XVIII

Croconazole Hydrochloride

Cyanamide

Cyclopentolate Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2243

Cycloserine

L-Cysteine

L-Cysteine Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2244 Infrared Reference Spectra JP XVIII

L-Cystine

Cytarabine

Danazol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2245

Dantrolene Sodium Hydrate

Daunorubicin Hydrochloride

Deferoxamine Mesilate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2246 Infrared Reference Spectra JP XVIII

Demethylchlortetracycline Hydrochloride

Dexamethasone

Dextromethorphan Hydrobromide Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2247

Diazepam

Dibucaine Hydrochloride

Diclofenac Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2248 Infrared Reference Spectra JP XVIII

Dicloxacillin Sodium Hydrate

Diflorasone Diacetate

Diflucortolone Valerate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2249

Digoxin

Dihydrocodeine Phosphate

Dihydroergotamine Mesilate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2250 Infrared Reference Spectra JP XVIII

Dihydroergotoxine Mesilate

Dilazep Hydrochloride Hydrate

Dimemorfan Phosphate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2251

Dimercaprol

Dimorpholamine

Dinoprost

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2252 Infrared Reference Spectra JP XVIII

Diphenhydramine Hydrochloride

Dipyridamole

Disopyramide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2253

Distigmine Bromide

Disulfiram

Dobutamine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2254 Infrared Reference Spectra JP XVIII

Docetaxel Hydrate

Domperidone

Donepezil Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2255

Dopamine Hydrochloride

Doripenem Hydrate

Dorzolamide Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2256 Infrared Reference Spectra JP XVIII

Doxapram Hydrochloride Hydrate

Doxazosin Mesilate

Doxifluridine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2257

Doxorubicin Hydrochloride

Doxycycline Hydrochloride Hydrate

Droperidol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2258 Infrared Reference Spectra JP XVIII

Droxidopa

Dydrogesterone

Ebastine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2259

Ecabet Sodium Hydrate

Edaravone

Emedastine Fumarate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2260 Infrared Reference Spectra JP XVIII

Emorfazone

Enalapril Maleate

Enflurane

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2261

Enoxacin Hydrate

Entacapone

Epalrestat

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2262 Infrared Reference Spectra JP XVIII

Eperisone Hydrochloride

Ephedrine Hydrochloride

Eplerenone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2263

Ergocalciferol

Erythromycin

Erythromycin Ethylsuccinate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2264 Infrared Reference Spectra JP XVIII

Erythromycin Stearate

Estradiol Benzoate

Estriol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2265

Ethanol

Anhydrous Ethanol

Ethenzamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2266 Infrared Reference Spectra JP XVIII

Ethionamide

Ethylcellulose

Ethyl L-Cysteine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2267

Ethyl Icosapentate

Ethyl Loflazepate

Ethylmorphine Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2268 Infrared Reference Spectra JP XVIII

Ethyl Parahydroxybenzoate

Etidronate Disodium

Etilefrine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2269

Etizolam

Etodolac

Etoposide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2270 Infrared Reference Spectra JP XVIII

Famotidine

Felbinac

Felodipine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2271

Fenbufen

Fenofibrate

Fentanyl Citrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2272 Infrared Reference Spectra JP XVIII

Fexofenadine Hydrochloride

Flavin Adenine Dinucleotide Sodium

Flavoxate Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2273

Flecainide Acetate

Flomoxef Sodium

Flopropione

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2274 Infrared Reference Spectra JP XVIII

Fluconazole

Fludiazepam

Fludrocortisone Acetate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2275

Flunitrazepam

Fluocinolone Acetonide

Fluorometholone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2276 Infrared Reference Spectra JP XVIII

Fluphenazine Enanthate

Flurazepam Hydrochloride

Flurbiprofen

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2277

Flutamide

Flutoprazepam

Fluvoxamine Maleate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2278 Infrared Reference Spectra JP XVIII

Formoterol Fumarate Hydrate

Fosfomycin Calcium Hydrate

Fosfomycin Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2279

Fructose

Fudosteine

Furosemide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2280 Infrared Reference Spectra JP XVIII

Fursultiamine Hydrochloride

Gatifloxacin Hydrate

Gefarnate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2281

Gefitinib

Glibenclamide

Gliclazide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2282 Infrared Reference Spectra JP XVIII

Glimepiride

L-Glutamic Acid

L-Glutamine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2283

Glutathione

Glycerin

Concentrated Glycerin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2284 Infrared Reference Spectra JP XVIII

Glycine

Gonadorelin Acetate

Guaifenesin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2285

Guanabenz Acetate

Guanethidine Sulfate

Haloperidol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2286 Infrared Reference Spectra JP XVIII

Halothane

Haloxazolam

L-Histidine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2287

L-Histidine Hydrochloride Hydrate

Homochlorcyclizine Hydrochloride

Hydralazine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2288 Infrared Reference Spectra JP XVIII

Hydrocortisone

Hydrocortisone Butyrate

Hydrocortisone Sodium Phosphate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2289

Hydrocortisone Sodium Succinate

Hydrocortisone Succinate

Hydrocotarnine Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2290 Infrared Reference Spectra JP XVIII

Hydroxypropylcellulose

Low Substituted Hydroxypropylcellulose

Hymecromone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2291

Hypromellose Phthalate (200731)

Hypromellose Phthalate (220824)

Ibudilast

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2292 Infrared Reference Spectra JP XVIII

Ibuprofen

Ibuprofen Piconol

Ifenprodil Tartrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2293

Imidapril Hydrochloride

Imipenem Hydrate

Indapamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2294 Infrared Reference Spectra JP XVIII

Indenolol Hydrochloride

Indometacin

Iohexol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2295

Iopamidol

Iotalamic Acid

Iotroxic Acid

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2296 Infrared Reference Spectra JP XVIII

Ipratropium Bromide Hydrate

Ipriflavone

Irbesartan

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2297

Irinotecan Hydrochloride Hydrate

Irsogladine Maleate

Isoflurane

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2298 Infrared Reference Spectra JP XVIII

L-Isoleucine

Isoniazid

Isosorbide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2299

Isosorbide Mononitrate

Isoxsuprine Hydrochloride

Itraconazole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2300 Infrared Reference Spectra JP XVIII

Ketamine Hydrochloride

Ketoconazole

Ketoprofen

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2301

Ketotifen Fumarate

Kitasamycin Acetate

Kitasamycin Tartrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2302 Infrared Reference Spectra JP XVIII

Labetalol Hydrochloride

Anhydrous Lactose

Lactose Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2303

Lafutidine

Lanoconazole

Lansoprazole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2304 Infrared Reference Spectra JP XVIII

Latamoxef Sodium

Lenampicillin Hydrochloride

L-Leucine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2305

Leuprorelin Acetate

Levallorphan Tartrate

Levofloxacin Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2306 Infrared Reference Spectra JP XVIII

Lidocaine

Lincomycin Hydrochloride Hydrate

Lisinopril Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2307

Lobenzarit Sodium

Lorazepam

Losartan Potassium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2308 Infrared Reference Spectra JP XVIII

Loxoprofen Sodium Hydrate

L-Lysine Acetate

L-Lysine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2309

Manidipine Hydrochloride

D-Mannitol

Maprotiline Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2310 Infrared Reference Spectra JP XVIII

Medazepam

Medroxyprogesterone Acetate

Mefloquine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2311

Mefruside

Menatetrenone

Mepitiostane

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2312 Infrared Reference Spectra JP XVIII

Mepivacaine Hydrochloride

Mequitazine

Mesalazine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2313

Mestranol

Metenolone Acetate

Metformin Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2314 Infrared Reference Spectra JP XVIII

L-Methionine

Methotrexate

Methyldopa Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2315

dl-Methylephedrine Hydrochloride

Methyl Parahydroxybenzoate

Methylprednisolone Succinate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2316 Infrared Reference Spectra JP XVIII

Methyltestosterone

Meticrane

Metildigoxin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2317

Metoprolol Tartrate

Metronidazole

Mexiletine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2318 Infrared Reference Spectra JP XVIII

Miconazole

Midecamycin

Midecamycin Acetate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2319

Miglitol

Minocycline Hydrochloride

Mitiglinide Calcium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2320 Infrared Reference Spectra JP XVIII

Mitomycin C

Mizoribine

Montelukast Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2321

Morphine Hydrochloride Hydrate

Morphine Sulfate Hydrate

Mosapride Citrate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2322 Infrared Reference Spectra JP XVIII

Nabumetone

Nafamostat Mesilate

Naftopidil

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2323

Nalidixic Acid

Naloxone Hydrochloride

Naproxen

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2324 Infrared Reference Spectra JP XVIII

Nateglinide

Neostigmine Methylsulfate

Nicardipine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2325

Nicergoline

Niceritrol

Nicomol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2326 Infrared Reference Spectra JP XVIII

Nicorandil

Nifedipine

Nilvadipine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2327

Nitrendipine

Nizatidine

Noradrenaline

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2328 Infrared Reference Spectra JP XVIII

Norethisterone

Norfloxacin

Norgestrel

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2329

Nortriptyline Hydrochloride

Noscapine

Ofloxacin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2330 Infrared Reference Spectra JP XVIII

Olmesartan Medoxomil

Olopatadine Hydrochloride

Omeprazole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2331

Oxapium Iodide

Oxaprozin

Oxethazaine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2332 Infrared Reference Spectra JP XVIII

Oxprenolol Hydrochloride

Oxycodone Hydrochloride Hydrate

Oxymetholone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2333

Oxytetracycline Hydrochloride

Ozagrel Sodium

Pancuronium Bromide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2334 Infrared Reference Spectra JP XVIII

Panipenem

Paroxetine Hydrochloride Hydrate

Pazufloxacin Mesilate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2335

Pemirolast Potassium

Penbutolol Sulfate

Pentobarbital Calcium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2336 Infrared Reference Spectra JP XVIII

Pentoxyverine Citrate

Peplomycin Sulfate

Pethidine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2337

Phenethicillin Potassium

Phenobarbital

L-Phenylalanine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2338 Infrared Reference Spectra JP XVIII

Phytonadione

Pilsicainide Hydrochloride Hydrate

Pimozide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2339

Pindolol

Pioglitazone Hydrochloride

Pipemidic Acid Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2340 Infrared Reference Spectra JP XVIII

Piperacillin Hydrate

Piperacillin Sodium

Piperazine Adipate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2341

Piperazine Phosphate Hydrate

Pirenoxine

Pirenzepine Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2342 Infrared Reference Spectra JP XVIII

Piroxicam

Pivmecillinam Hydrochloride

Polaprezinc

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2343

Potassium Canrenoate

Potassium Clavulanate

Povidone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2344 Infrared Reference Spectra JP XVIII

Pranlukast Hydrate

Pranoprofen

Prasterone Sodium Sulfate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2345

Prazepam

Prazosin Hydrochloride

Prednisolone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2346 Infrared Reference Spectra JP XVIII

Prednisolone Acetate

Prednisolone Sodium Phosphate

Prednisolone Succinate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2347

Probucol

Procainamide Hydrochloride

Procaine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2348 Infrared Reference Spectra JP XVIII

Procarbazine Hydrochloride

Procaterol Hydrochloride Hydrate

Progesterone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2349

Proglumide

L-Proline

Promethazine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2350 Infrared Reference Spectra JP XVIII

Propafenone Hydrochloride

Propiverine Hydrochloride

Propranolol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2351

Propyl Parahydroxybenzoate

Protirelin

Purified Sodium Hyaluronate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2352 Infrared Reference Spectra JP XVIII

Pyrantel Pamoate

Pyrazinamide

Pyridoxal Phosphate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2353

Pyridoxine Hydrochloride

Pyrrolnitrin

Quetiapine Fumarate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2354 Infrared Reference Spectra JP XVIII

Quinapril Hydrochloride

Quinine Ethyl Carbonate

Quinine Sulfate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2355

Rabeprazole Sodium

Ranitidine Hydrochloride

Rebamipide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2356 Infrared Reference Spectra JP XVIII

Reserpine

Ribavirin

Rifampicin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2357

Rilmazafone Hydrochloride Hydrate

Risperidone

Ritodrine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2358 Infrared Reference Spectra JP XVIII

Rosuvastatin Calcium

Roxatidine Acetate Hydrochloride

Roxithromycin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2359

Saccharin

Salbutamol Sulfate

Salicylic Acid

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2360 Infrared Reference Spectra JP XVIII

Santonin

Sarpogrelate Hydrochloride

Scopolamine Butylbromide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2361

L-Serine

Sevoflurane

Silodosin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2362 Infrared Reference Spectra JP XVIII

Simvastatin

Sitagliptin Phosphate Hydrate

Sivelestat Sodium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2363

Sodium Fusidate

Sodium Lauryl Sulfate

Sodium Picosulfate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2364 Infrared Reference Spectra JP XVIII

Sodium Polystyrene Sulfonate

Sodium Risedronate Hydrate

Sodium Salicylate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2365

Sodium Starch Glycolate, Type A

Sodium Starch Glycolate, Type B

Sodium Valproate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2366 Infrared Reference Spectra JP XVIII

Spiramycin Acetate

Spironolactone

Sucrose

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2367

Sulbactam Sodium

Sulbenicillin Sodium

Sulfadiazine Silver

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2368 Infrared Reference Spectra JP XVIII

Sulfamethizole

Sulfamethoxazole

Sulfamonomethoxine Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2369

Sulindac

Sulpiride

Sultamicillin Tosilate Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2370 Infrared Reference Spectra JP XVIII

Suxamethonium Chloride Hydrate

Tacalcitol Hydrate

Tacrolimus Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2371

Talampicillin Hydrochloride

Taltirelin Hydrate

Tamoxifen Citrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2372 Infrared Reference Spectra JP XVIII

Tamsulosin Hydrochloride

Taurine

Tazobactam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2373

Tegafur

Telmisartan

Temocapril Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2374 Infrared Reference Spectra JP XVIII

Teprenone

Terbinafine Hydrochloride

Testosterone Propionate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2375

Tetracycline Hydrochloride

Theophylline

Thiamine Chloride Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2376 Infrared Reference Spectra JP XVIII

Thiamylal Sodium

Thioridazine Hydrochloride

L-Threonine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2377

Tiapride Hydrochloride

Tiaramide Hydrochloride

Ticlopidine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2378 Infrared Reference Spectra JP XVIII

Timepidium Bromide Hydrate

Timolol Maleate

Tinidazole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2379

Tipepidine Hibenzate

Tizanidine Hydrochloride

Tocopherol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2380 Infrared Reference Spectra JP XVIII

Tocopherol Acetate

Tocopherol Calcium Succinate

Tocopherol Nicotinate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2381

Todralazine Hydrochloride Hydrate

Tofisopam

Tolnaftate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2382 Infrared Reference Spectra JP XVIII

Tosufloxacin Tosilate Hydrate

Tramadol Hydrochloride

Tranexamic Acid

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2383

Tranilast

Trehalose Hydrate

Triamcinolone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2384 Infrared Reference Spectra JP XVIII

Triamcinolone Acetonide

Triazolam

Trichlormethiazide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2385

Triclofos Sodium

Trientine Hydrochloride

Trimebutine Maleate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2386 Infrared Reference Spectra JP XVIII

Trimetazidine Hydrochloride

Trimethadione

Trimetoquinol Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2387

Troxipide

L-Tryptophan

Tulobuterol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2388 Infrared Reference Spectra JP XVIII

Tulobuterol Hydrochloride

L-Tyrosine

Ubenimex

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2389

Ubidecarenone

Urapidil

Ursodeoxycholic Acid

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2390 Infrared Reference Spectra JP XVIII

Valaciclovir Hydrochloride

L-Valine

Valsartan

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2391

Vancomycin Hydrochloride

Verapamil Hydrochloride

Vinblastine Sulfate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2392 Infrared Reference Spectra JP XVIII

Vincristine Sulfate

Voglibose

Voriconazole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2393

Warfarin Potassium

Xylitol

Zaltoprofen

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2394 Infrared Reference Spectra JP XVIII

Zidovudine

Zolpidem Tartrate

Zonisamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVIII Infrared Reference Spectra 2395

Zopiclone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)